Extreme Prematurity Clinical Trials

5 recruiting

Extreme Prematurity Trials at a Glance

7 actively recruiting trials for extreme prematurity are listed on ClinicalTrialsFinder across 6 cities in 8 countries. The largest study group is Not Applicable with 3 trials, with the heaviest enrollment activity in Paris, Birmingham, and Bron. Lead sponsors running extreme prematurity studies include Hospices Civils de Lyon, Institut National de la Santé Et de la Recherche Médicale, France, and Anna M Kidman.

Browse extreme prematurity trials by phase

Treatments under study

About Extreme Prematurity Clinical Trials

Looking for clinical trials for Extreme Prematurity? There are currently 5 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Extreme Prematurity trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Extreme Prematurity clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 17 of 7 trials

Recruiting

Long Term Follow-up of the TREOCAPA Study (TREOCAPA-LT)

Patency of the Ductus Arteriosus Acetaminophen Extreme Prematurity
Institut National de la Santé Et de la Recherche Médicale, France500 enrolled8 locationsNCT06064825
Recruiting
Not Applicable

Ventilator Pressure and Optimization of Compliance and Hemodynamics

Pulmonary Hypertension Due to Lung Diseases and HypoxiaBronchopulmonary DysplasiaExtreme Prematurity+2 more
University of Alabama at Birmingham24 enrolled1 locationNCT06512935
Recruiting

Dopamine vs. Norepinephrine for Hypotension in Very Preterm Infants With Late-onset Sepsis

Extreme PrematurityLate-Onset Neonatal SepsisNeonatal Hypotension
Mount Sinai Hospital, Canada550 enrolled23 locationsNCT05347238
Recruiting

Oral Feeding Skills of Very Premature Infants

Extreme Prematurity (gestational Age Below 29 Weeks)
Hospices Civils de Lyon40 enrolled1 locationNCT06657729
Recruiting
Not Applicable

Open Lung Maneuvers During High Frequency Oscillatory Ventilation in Preterm Infants

Extreme PrematurityHigh Frequency Oscillation VentilationLung Injury, Acute
Medical University of Vienna36 enrolled1 locationNCT04289324
Recruiting
Not Applicable

Early Intervention Based on Neonatal Crawling in Very Premature Infants at Risk For Neurodevelopmental Disorder

Infant DevelopmentExtreme PrematurityPrematurity+2 more
Marianne Barbu-Roth50 enrolled3 locationsNCT06027645
Recruiting

In extremely preterm infants less than 28 weeks gestation who are receiving invasive mechanical ventilation, does extubation to a higher level of continuous positive airway pressure compared to standard practice prevent deterioration and return to mechanical ventilation.

Extreme Prematurity
Anna M Kidman200 enrolled3 locationsACTRN12618001638224